Patient/advocate Diane Redington and Dr. Marcela del Carmen discuss the importance of clinical trials and the extreme lack of funding for gynecological cancer research. This is part eight of a nine-part series.
Dr. Marcela del Carmen explains that the field is on the forefront of major discoveries in understanding the biology of this carcinosarcoma; however, a severe lack of funding is limiting progress. Due to lack of funding, in the past year, we have gone from having 2000 patients in clinical trials to less than 200.
Read the video transcript – Click here